Literature DB >> 36186240

Predicting Intravenous Immunoglobulin Resistance Among North American Children Hospitalized With Kawasaki Disease.

Jasdip Singh1, Arthur Chang2, Nicholas M Fusco1, Mark Hicar2.   

Abstract

OBJECTIVE: The Kobayashi score (KS) is the most widely used tool for predicting intravenous immunoglobulin (IVIG) resistance in Kawasaki disease (KD). The KS has shown good sensitivity (86%) and specificity (68%) in Japanese children; however, its use is limited outside of Japan. No models accurately predict IVIG resistance of children with KD in the United States. We sought to develop and test a novel scoring system to predict IVIG resistance in hospitalized children with KD.
METHODS: A retrospective chart review was conducted of all children diagnosed with KD from January 2000 to December 2015. Subjects were divided into 2 groups: IVIG susceptible or resistant. Variables that differed between the groups were identified and used to create a "new score" to predict resistance to IVIG. The new score was then compared with the KS and performance characteristics were determined.
RESULTS: A total of 208 subjects were reviewed. White blood cell count, neutrophil percentage, age, and serum albumin were used in the new score with equal weighting. Overall, the new score achieved improved sensitivity (54% vs 26%) and similar specificity (69% vs 74%) compared with the KS in predicting IVIG resistance in hospitalized children diagnosed with KD.
CONCLUSIONS: Predicting IVIG resistance in children diagnosed with KD remains challenging. The KS has low sensitivity in predicting IVIG resistance in children with KD in the United States. The new score resulted in improved sensitivity, but many children with true IVIG resistance may be missed. Further research is needed to improve IVIG resistance prediction. Copyright. Pediatric Pharmacy Association. All rights reserved. For permissions, email: membership@pediatricpharmacy.org 2022.

Entities:  

Keywords:  Kawasaki disease; Kobayashi score; coronary artery aneurysm; intravenous immunoglobulin resistance

Year:  2022        PMID: 36186240      PMCID: PMC9514769          DOI: 10.5863/1551-6776-27.7.669

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  20 in total

1.  Abnormal liver panel in acute kawasaki disease.

Authors:  Mohammed Eladawy; Samuel R Dominguez; Marsha S Anderson; Mary P Glodé
Journal:  Pediatr Infect Dis J       Date:  2011-02       Impact factor: 2.129

2.  Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.

Authors:  Tohru Kobayashi; Yoshinari Inoue; Kazuo Takeuchi; Yasunori Okada; Kazushi Tamura; Takeshi Tomomasa; Tomio Kobayashi; Akihiro Morikawa
Journal:  Circulation       Date:  2006-05-30       Impact factor: 29.690

3.  Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.

Authors:  Tetsuya Sano; Shunji Kurotobi; Kouji Matsuzaki; Takehisa Yamamoto; Ichiro Maki; Kazunori Miki; Shigetoyo Kogaki; Junichi Hara
Journal:  Eur J Pediatr       Date:  2006-08-01       Impact factor: 3.183

4.  Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.

Authors:  Kimiyasu Egami; Hiromi Muta; Masahiro Ishii; Kenji Suda; Yoko Sugahara; Motofumi Iemura; Toyojiro Matsuishi
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

5.  Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.

Authors:  Lynn A Sleeper; L Luann Minich; Brian M McCrindle; Jennifer S Li; Wilbert Mason; Steven D Colan; Andrew M Atz; Beth F Printz; Annette Baker; Victoria L Vetter; Jane W Newburger
Journal:  J Pediatr       Date:  2010-12-18       Impact factor: 4.406

6.  Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.

Authors:  H Koyanagi; Y Nakamura; H Yanagawa
Journal:  Acta Paediatr       Date:  1998-01       Impact factor: 2.299

Review 7.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

8.  The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis.

Authors:  Ling Liu; Wei Yin; Ruigeng Wang; Dongming Sun; Xuelian He; Yan Ding
Journal:  Inflamm Res       Date:  2015-12-08       Impact factor: 4.575

9.  Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.

Authors:  Shu Wu; Ying Liao; Yan Sun; Chun-Yu Zhang; Qing-You Zhang; Hui Yan; Jian-Guang Qi; Xue-Qin Liu; Yong-Hong Chen; Yu-Li Wang; Xue-Ying Li; Hong-Fang Jin; Jun-Bao Du
Journal:  World J Pediatr       Date:  2020-03-30       Impact factor: 2.764

10.  Correction: A machine learning approach to predict intravenous immunoglobulin resistance in Kawasaki disease patients: A study based on a Southeast China population.

Authors:  Tengyang Wang; Guanghua Liu; Hongye Lin
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.